Publication | Closed Access

Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial

S-1 Versus GemcitabineGastrointestinal OncologyMedicineBiliary CancerPathologyMolecular OncologyCancer TreatmentOncologyRadiation OncologyCancer Research